{"id":1068013,"date":"2021-05-26T01:51:25","date_gmt":"2021-05-26T05:51:25","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/obseva-announces-proposed-changes-to-the-composition-of-its-board-of-directors\/"},"modified":"2024-08-18T11:41:55","modified_gmt":"2024-08-18T15:41:55","slug":"obseva-announces-proposed-changes-to-the-composition-of-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/obseva-announces-proposed-changes-to-the-composition-of-its-board-of-directors.php","title":{"rendered":"ObsEva Announces Proposed Changes to the Composition of its Board of Directors"},"content":{"rendered":"<p><![CDATA[Geneva, Switzerland\u00a0and\u00a0Boston, MA\u00a0\u2013\u00a0May 25, 2021\u00a0\u2013\u00a0ObsEva SA\u00a0(NASDAQ: OBSV \/ SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women\u2019s reproductive health, today announced that its Board of Directors will propose the election at the 2021 Annual General Meeting of Shareholders to be held on\u00a0May 28, 2021 of Anne VanLent as member of the Board of Directors for a term of one year expiring at the closing of the 2022 Annual General Meeting of Shareholders.]]><\/p>\n<p>View post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/05\/25\/2235922\/0\/en\/ObsEva-Announces-Proposed-Changes-to-the-Composition-of-its-Board-of-Directors.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"ObsEva Announces Proposed Changes to the Composition of its Board of Directors\">ObsEva Announces Proposed Changes to the Composition of its Board of Directors<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>View post: ObsEva Announces Proposed Changes to the Composition of its Board of Directors <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/obseva-announces-proposed-changes-to-the-composition-of-its-board-of-directors.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068013","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068013"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068013"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068013\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}